The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment
Non-small cell lung cancer (NSCLC) is a prominent etiology of cancer-related mortality. The heterogeneous nature of this disease impedes its accurate diagnosis and efficacious treatment. Consequently, constant advancements in research are imperative in order to comprehend its intricate nature. In ad...
Main Authors: | Lei Peng, Quan Xu, Sui Yin, Ye Zhang, Hao Wu, Yangchun Liu, Liru Chen, Yeji Hu, Jun Yuan, Kai Peng, Qin Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1153319/full |
Similar Items
-
Nanomedicine in Lung Cancer Immunotherapy
by: Mohammad Doroudian, et al.
Published: (2023-03-01) -
Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
by: Coral García-Fernández, et al.
Published: (2020-06-01) -
Polymers in nanomedicine /
by: Kunugi, Shigeru, et al.
Published: (c201) -
The handbook of nanomedicine /
by: Jain, K. K. (Kewal K.)
Published: (2008) -
Nanomedicine in health and disease /
by: Hunter, Ross J. (Ross Jacob), 1977- 531055, et al.
Published: (c201)